Indian stocks: Visit www.stage2stocks.com →

Cronos Group Inc.

Stage 2 · Advancing · week 23

As of Oct 22, 2026, Cronos Group is in Stage 2, the uptrend phase, now in week 23 (since May 12, 2026). It closed at $3.45, 3.0% below its 52-week high and above its 200-day average, which is rising.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. More about the company

$3.45
+2.14% today
$1.3B · Small cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 26 in Drug Manufacturers - Specialty & Generic · #1 of 272 in Health Care

Is CRON early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 25w
S4 36w
S2 17w
S2 23w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 10w → S2 3w → S3 5w → S2 25w → S3 12w → S4 36w → S1 7w → S2 17w → S3 5w → S2 11w → S3 10w → S2 23w current
Total tracked: 165 weeks across 12 stage runs.

CRON among Drug Manufacturers - Specialty & Generic19th of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…19CRONStage 2 · wk 2381+1.3%
vs 52W High
-3.0%
$2.30 lo$3.55 hi
3.0% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 23
1w13w26w
Week 23, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
21.6%
200 DMA: $2.83 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.95x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+1.3%
3M
+22.6%
6M
+32.5%
YTD
+27.6%
1Y
+37.8%
Scan Membership
Breakout Watch
Latest: 2023-12-29
4 appearances in last 60 days. First seen: 2018-12-31.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 23 · Vol 0.95x
2026-10-21S2
Wk 23 · Vol 1.06x
2026-10-20S2
Wk 23 · Vol 0.83x
2026-10-19S2
Wk 23 · Vol 0.73x
2026-10-16S2
Wk 22 · Vol 0.73x
2026-10-15S2
Wk 22 · Vol 0.67x
2026-10-14S2
Wk 22 · Vol 0.79x
2026-10-13S2
Wk 22 · Vol 0.42x
2026-10-12S2
Wk 22 · Vol 0.56x
2026-10-09S2
Wk 21 · Vol 0.34x
2026-10-08S2
Wk 21 · Vol 0.79x
2026-10-07S2
Wk 21 · Vol 0.37x
Moving averages & range
50 DMA
$3.28
200 DMA
$2.83
52W High
$3.55
52W Low
$2.30
5D Low
$3.21
Resistance levels (recent highs)
20d High
$3.45
60d High
$3.55
120d High
$3.55
250d High
$3.55
Next resistance
+3.0%
to 60d High
P/E (TTM)
18.1
Forward -86.1
ROE
+7.0%
Profit margin +39.1%
Dividend Yield
0.00%
P/B 1.2

Cronos Group: quick answers

What stage is Cronos Group in?

As of Oct 22, 2026, Cronos Group (CRON) is in Stage 2, the uptrend phase. It entered Stage 2 on May 12, 2026 and is in week 23. What the four stages mean

Is Cronos Group in an uptrend?

Yes. Cronos Group is in a Stage 2 uptrend. It trades 21.6% above its 200-day average, which is rising.

How far is Cronos Group from its 52-week high?

Cronos Group closed at $3.45 on Oct 22, 2026, 3.0% below its 52-week high of $3.55. Its 52-week low is $2.30.

How has Cronos Group performed over the past year?

As of Oct 22, 2026, Cronos Group is up 37.8% over the past year and up 27.6% so far in 2026.

Which sector and industry is Cronos Group in?

Cronos Group is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.